TITLE

"No turning back" on cheap AIDS drugs for poor nations, UN vows

AUTHOR(S)
Silversides, Ann
PUB. DATE
November 2003
SOURCE
CMAJ: Canadian Medical Association Journal;11/11/2003, Vol. 169 Issue 10, p1067
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Emphasizes the need to modify the Patent Act in Ottawa, Ontario, to allow Canadian manufacturers of generic drugs to make and export drugs to developing countries. Implications of the proposed drug exportation for Canadian pharmaceutical companies; Impact of the decision of the World Trade Organization to modify international rules on patent protection on the affordability of prescription drugs for developing nations; Significance of the proposed modification of patent law to developing countries.
ACCESSION #
11235689

 

Related Articles

  • More Pills. Overdorf, Jason // Newsweek (Pacific Edition);4/4/2005 (Pacific Edition), Vol. 145 Issue 14, p6 

    Looks at the impact of pharmaceutical legislation passed in India. Report that India's government has passed a law governing patents, which will restrict the availability of generic drugs; Claim that India passed the law to meet the standards of the World Trade Organization; Plans of major...

  • More Pills. Overdorf, Jason // Newsweek (Atlantic Edition);4/4/2005 (Atlantic Edition), Vol. 145 Issue 14, p6 

    Looks at the impact of pharmaceutical legislation passed in India. Report that India's government has passed a law governing patents, which will restrict the availability of generic drugs; Claim that India passed the law to meet the standards of the World Trade Organization; Plans of major...

  • Indian law could choke cheap drug supply. Jayaraman, K. S. // Nature Medicine;May2005, Vol. 11 Issue 5, p460 

    Reports on criticism against a law passed by the Indian government forbidding local companies from manufacturing copies of drugs patented elsewhere. Claim of critics that the law will eventually raise the cost of generic drugs for millions of people in developing countries; Law permitting...

  • Canada to allow production of generic AIDS drugs.  // Nature Reviews Drug Discovery;Nov2003, Vol. 2 Issue 11, p854 

    Reports that Canadian Prime Minister-elect Paul Martin, has endorsed plans for the federal government to excuse poor countries from patent rules. Allowance for Canadian generic-drug makers to supply cheap medicines to developing countries undergoing health crises; Deal of the World Trade...

  • Patent policy and public health in developing countries: lessons from Japan. Aoki, Reiko; Kubo, Kensuke; Yamane, Hiroko // Bulletin of the World Health Organization;May2006, Vol. 84 Issue 5, p417 

    The article discusses on the implications of the World Trade Organization's Trade-Related Aspects of Intellectual Property Rights Agreement on the public health sector in developing countries. Under the product patent law, local pharmaceutical companies are restricted to copy manufactured drugs...

  • ASSESSING THE BARRIERS TO UNIVERSAL ANTIRETROVIRAL TREATMENT ACCESS FOR HIV/AIDS IN SOUTH AFRICA. Walker, Mary Beth // Duke Journal of Comparative & International Law;Fall2004, Vol. 15 Issue 1, p193 

    The article examines the struggle to universal access to antiretroviral (ARV) treatment for HIV and AIDS in South Africa. It highlights the impact of the world patent system regarding the access to medication of HIV and AIDS in developing countries. It mentions the country's 1997 Amendment to...

  • PRESERVING THE PHARMACY TO THE DEVELOPING WORLD. R. W. // Multinational Monitor;Mar/Apr2007, Vol. 28 Issue 2, p14 

    The article focuses on the issues concerning the pharmaceutical patent law in India. It states that treatment of people with HIV/AIDS in developing countries has depended on the existence of generic antiretroviral drugs (ARVs). Because of this, the World Trade Organization's Agreement on...

  • Patent expirations spell big changes for generic industry. Cassell, Dana K. // Drug Topics;8/6/2001 Supplement, Vol. 145 Issue 15, p9 

    Focuses on the increase of patent expirations among pharmaceutical industries in the United States. List of top eight drugs going off patent before December 2005; Delay of patent expiration due to court trials; Plan of an educational campaign on safety and efficacy of generic drugs.

  • EARNING EXCLUSIVITY: GENERIC DRUG INCENTIVES AND THE HATCH-WAXMAN ACT. Hemphill, C. Scott; Lemley, Mark A. // Antitrust Law Journal;Sep2011, Vol. 77 Issue 3, p947 

    No abstract available.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics